Reduced cancer-independent life expectancy in head, neck cancer

June 27, 2017

(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

Sean T. Massa, M.D., from St. Louis University, and colleagues calculated and years of life lost (YLL) for patients with head and neck cancer, referenced to the .

The researchers found that patients with head and neck cancer had cancer-independent life expectancy that was 6.5 years shorter than expected. Black race, stage IV, Medicaid, and previous marriage were associated with the greatest hazard (hazard ratios, 1.23, 1.60, 1.55, and 1.49, respectively) and impact of other-cause mortality (YLL, 8.55, 7.92, 12.9, and 11.4, respectively).

"Patients with head and lives are foreshortened independent of their cancer diagnosis necessitating management of noncancer mortality to maximize overall survival," the authors write.

Explore further: More side effects with CRT plus metformin in head, neck cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

More side effects with CRT plus metformin in head, neck cancer

May 7, 2017
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...

Metformin linked to lower risk of head, neck cancer

September 9, 2015
(HealthDay)—Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in the September issue of Head & Neck.

Racial disparity in head and neck cancer outcomes

April 19, 2013
(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in JAMA Otolaryngology-Head ...

High CVD risk in patients with head, neck squamous cell cancer

February 2, 2017
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published ...

Geographic variation in HPV oropharyngeal cancer prevalence

January 15, 2016
(HealthDay)—There is geographic variation in the proportion of head and neck cancers attributable to human papillomavirus (HPV), according to a study published online Jan. 8 in Head & Neck.

Neuromuscular stimulation doesn't aid dysphagia patients

October 23, 2015
(HealthDay)—Neuromuscular electrical stimulation (NMES) does not add benefit to traditional swallow exercises for patients experiencing dysphagia after treatment for head and neck cancer, according to a study published ...

Recommended for you

Tracking how multiple myeloma evolves by sequencing DNA in the blood

December 10, 2017
Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, ...

Landmark CAR-T cancer study published

December 10, 2017
Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Study finds emojis promising tool for tracking cancer patients' quality of life

December 10, 2017
In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients' physical, emotional and overall quality ...

Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant

December 10, 2017
Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial ...

Blood test may help predict which breast cancers will recur

December 8, 2017
A blood test five years after breast cancer treatment helped identify some women who were more likely to relapse, long before a lump or other signs appeared, a preliminary study found.

Alcohol-abuse drug Antabuse kills cancer cells

December 8, 2017
A new study in Nature by an international team including researchers from Karolinska Institutet, reports that the alcohol-abuse drug Antabuse is effective against cancer. The study also identifies a potential mechanism of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.